FDA Set To Cut Off 17,000 Women Annually From Lifesaving Drug

    From the diaries by lexington_concord… Obama’s Food and Drug Administration (FDA) is due to take up the case of Avastin, a cancer drug that successfully treats some 17,000 women annually. With a coming December 17 decision, the FDA seems poised to take this drug away from these patients quite despite the fact that their doctors find the drug effective. The most dangerous period of time | Read More »

    Feds Deciding When Healthcare Science Costs Too Much To Save Lives

    If anyone wants a current example of what is looming ahead for medical science at the hands of Obamacare, the Avastin controversy is a perfect one. The Food and Drug Administration (FDA) wants to de-list the cancer drug Avastin one reason being that it is a drug too expensive for government to fund. It is scary to think that the federal government can summarily dismiss | Read More »